Hagopian Louis P, Rooker Griffin W, Yenokyan Gayane
The Kennedy Krieger Institute.
Johns Hopkins University School of Medicine.
J Appl Behav Anal. 2018 Jul;51(3):443-465. doi: 10.1002/jaba.477. Epub 2018 May 21.
Predictive biomarkers (PBioMs) are objective biological measures that predict response to medical treatments for diseases. The current study translates methods used in the field of precision medicine to identify PBioMs to identify parallel predictive behavioral markers (PBMs), defined as objective behavioral measures that predict response to treatment. We demonstrate the utility of this approach by examining the accuracy of two PBMs for automatically reinforced self-injurious behavior (ASIB). Results of the analysis indicated both functioned as good to excellent PBMs. We discuss the compatibility of this approach with applied behavior analysis, describe methods to identify additional PBMs, and posit that variables related to the mechanisms of problem behavior and putative mechanism of treatment action hold the most promise as potential PBMs. We discuss how this technology could guide individualized treatment selection, inform our understanding of problem behavior and mechanisms of treatment action, and help determine the conditional effectiveness of clinical procedures.
预测性生物标志物(PBioMs)是预测疾病医疗治疗反应的客观生物学指标。当前研究将精准医学领域用于识别PBioMs的方法进行转化,以识别平行预测行为标志物(PBMs),其被定义为预测治疗反应的客观行为指标。我们通过检验两种用于自动强化自伤行为(ASIB)的PBMs的准确性来证明这种方法的实用性。分析结果表明二者均发挥了良好至优异的PBMs作用。我们讨论了这种方法与应用行为分析的兼容性,描述了识别其他PBMs的方法,并假定与问题行为机制和假定治疗作用机制相关的变量作为潜在PBMs最具前景。我们讨论了这项技术如何指导个体化治疗选择,增进我们对问题行为和治疗作用机制的理解,并有助于确定临床程序的条件有效性。